Informations sur le produit
- N-Hydroxy-N'-phenyl-octanediamideZolinzaSAHA
- Ccris 8456
- M344
- N-Hydroxy-N'-phenyloctanediamide
- N-Hyrdroxy-N'-phenyloctanediamide
- N<sup>1</sup>-Hydroxy-N<sup>8</sup>-phenyloctanediamide
- Octanediamide, N-hydroxy-N'-phenyl-
- Octanediamide, N<sup>1</sup>-hydroxy-N<sup>8</sup>-phenyl-
- SAHA cpd
- Suberanilohydroxamic acid
- Voir d'autres synonymes
- Suberoyl anilide bishydroxamide
- Suberoylanilide Hydroxamic Acid
- Unii-58Ifb293Ji
- Vorinostat [USAN]
- Wt 171
- Zolinza
- Octanediamide, N1-hydroxy-N8-phenyl-
- SAHA
- N1-Hydroxy-N8-phenyloctanediamide
Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It is used to treat cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. This drug inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II).
Vorinostat is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.
Propriétés chimiques
Question d’ordre technique sur : 3D-BV164560 Vorinostat - Bio-X ™
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages